AMP Capital Investors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-13,183
Closed -$1.3M 1187
2017
Q3
$1.3M Buy
13,183
+4,862
+58% +$471K 0.01% 827
2017
Q2
$831K Sell
8,321
-6,818
-45% -$735K ﹤0.01% 896
2017
Q1
$1.73M Sell
15,139
-8,000
-35% -$930K 0.01% 760
2016
Q4
$2.76M Sell
23,139
-271
-1% -$30K 0.02% 667
2016
Q3
$2.59M Sell
23,410
-5,600
-19% -$645K 0.02% 661
2016
Q2
$3.52M Buy
29,010
+9,345
+48% +$1.13M 0.02% 577
2016
Q1
$2.25M Buy
19,665
+6,300
+47% +$655K 0.02% 682
2015
Q4
$1.43M Buy
13,365
+200
+2% +$22.9K 0.01% 781
2015
Q3
$1.29M Buy
13,165
+1,517
+13% +$165K 0.01% 779
2015
Q2
$1.33M Hold
11,648
0.01% 817
2015
Q1
$1.21M Hold
11,648
0.01% 845
2014
Q4
$1.4M Sell
11,648
-34,001
-74% -$4.47M 0.01% 823
2014
Q3
$6.77M Sell
45,649
-933
-2% -$144K 0.04% 432
2014
Q2
$7.73M Buy
46,582
+26,701
+134% +$4.75M 0.05% 417
2014
Q1
$3.97M Buy
19,881
+4,381
+28% +$827K 0.03% 548
2013
Q4
$2.95M Sell
15,500
-14,973
-49% -$2.79M 0.02% 641
2013
Q3
$5.16M Sell
30,473
-4,731
-13% -$734K 0.04% 480
2013
Q2
$5.38M Buy
+35,204
New +$4.99M 0.04% 455

Other funds holding CLB

AMP Capital Investors's CLB Position: Q4 2017 in Review

AMP Capital Investors sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 13,183 shares — an estimated $1.3M sold.

AMP Capital Investors first reported a position in CLB in Q2 2013 and held it in 18 quarters. The position peaked at $7.73M in Q2 2014. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • AMP Capital Investors reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • AMP Capital Investors sold 13,183 Core Laboratories shares in Q4 2017, an estimated $1.3M.
  • AMP Capital Investors first reported a position in Core Laboratories in Q2 2013 and held it in 18 quarters.
  • AMP Capital Investors's Core Laboratories position peaked at $7.73M in Q2 2014.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on AMP Capital Investors's 13F filing for Q4 2017, filed 14 Feb 2018.